Rituximab Does Not Prevent Graft Loss in Renal Transplant Recipients With Chronic Antibody Mediated Rejection With Significant Renal Impairment and Nephrotic Range Proteinuria.

被引:0
|
作者
Anwar, S. [1 ]
Delos Santos, R. [1 ]
Horwedel, T. [1 ]
Brennan, D. [1 ]
Klein, C. [1 ]
机构
[1] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A273
引用
收藏
页码:477 / 477
页数:1
相关论文
共 50 条
  • [1] Rituximab Does Not Prevent Graft Loss in Renal Transplant Recipients With Chronic Antibody Mediated Rejection With Significant Renal Impairment and Nephrotic Range Proteinuria.
    Anwar, S.
    Delos Santos, R.
    Horwedel, T.
    Brennan, D.
    Klein, C.
    TRANSPLANTATION, 2014, 98 : 477 - 477
  • [2] Successful Treatment of Chronic Antibody-Mediated Rejection With IVIG and Rituximab in Pediatric Renal Transplant Recipients
    Billing, Heiko
    Rieger, Susanne
    Ovens, Joerg
    Suesal, Caner
    Melk, Anette
    Waldherr, Ruediger
    Opelz, Gerhard
    Toenshoff, Burkhard
    TRANSPLANTATION, 2008, 86 (09) : 1214 - 1221
  • [3] Role of proteinuria on graft loss and death in renal transplant recipients
    Cherif, M.
    Barbouch, S.
    Ounissi, M.
    Helel, I.
    Ben Abdallah, T.
    Abderrahim, E.
    Goucha, R.
    Ben Maiz, H.
    Ben Hamida, F.
    Kheder, A.
    NEPHROLOGY, 2008, 13 : A85 - A85
  • [4] Extended Experience with IVIG and Rituximab for Treatment of Chronic Antibody-Mediated Rejection in Pediatric Renal Transplant Recipients
    Billing, H.
    Suesal, C.
    Ovens, J.
    Waldherr, R.
    Opelz, G.
    Toenshoff, B.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1814 - 1814
  • [5] The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients
    An, Gun Hee
    Yun, Jintak
    Hong, Yu Ah
    Khvan, Marina
    Chung, Byung Ha
    Choi, Bum Soon
    Park, Cheol Whee
    Choi, Yeong Jin
    Kim, Yong-Soo
    Yang, Chul Woo
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014 : 828732
  • [6] Successful treatment with IVIG and rituximab for treatment of chronic antibody-mediated rejection in pediatric renal transplant recipients
    Billing, H.
    Suesal, C.
    Ovens, J.
    Waldherr, R.
    Opelz, G.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1616 - 1616
  • [7] Effectiveness of Rituximab and Intravenous Immunoglobulin Therapy in Renal Transplant Recipients with Chronic Active Antibody-Mediated Rejection
    Hong, Y. A.
    Kim, H. G.
    Choi, S. R.
    Sun, I. O.
    Park, H. S.
    Chung, B. H.
    Choi, B. S.
    Park, C. W.
    Kim, Y. S.
    Yang, C. W.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (01) : 182 - 184
  • [8] Extended Experience with IVIG and Rituximab for Treatment of Chronic Antibody-Mediated Rejection in Pediatric Renal Transplant Recipients
    Billing, Heiko
    Suesal, Caner
    Ovens, Joerg
    Waldherr, Ruediger
    Opelz, Gehard
    Toenshoff, Burkhard
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 416 - 416
  • [9] A rare case of vascular rejection in a renal transplant recipient with nephrotic range proteinuria
    Akioka, Kiyokazu
    Okamoto, Masahiko
    Ushigome, Hidetaka
    Nobori, Shuji
    Kozaki, Koichi
    Kaihara, Satoshi
    Urasaki, Koji
    Yanagisawa, Akio
    Morozumi, Kunio
    Yoshimura, Norio
    CLINICAL TRANSPLANTATION, 2007, 21 : 18 - 22
  • [10] Long-term outcomes of rituximab for antibody mediated rejection in paediatric renal transplant recipients
    Kim, Jon Jin
    Jones, Helen E.
    Marks, Stephen D.
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1819 - 1819